| Old Articles: <Older 46291-46300 Newer> |
 |
The Motley Fool December 31, 2010 Brian Orelli |
How the Other Half of Pharma Lives A dive into spec pharma.  |
The Motley Fool December 31, 2010 Anand Chokkavelu |
3 Homebuilders Near 52-Week Lows Trolling the bottom for upside potential.  |
The Motley Fool December 31, 2010 Andrew Bond |
Security Emerges From the Cloud The proliferation of cloud computing and concerns about safety should boost IT security stocks.  |
The Motley Fool December 31, 2010 Sean Williams |
3 Stocks Near 52-Week Highs Worth Selling Poor track records and/or high debt levels could derail these highfliers.  |
The Motley Fool December 31, 2010 Alex Dumortier |
Invest Like a Pro in 2011 -- Here's How Bet on stocks while reducing your risk exposure.  |
The Motley Fool December 31, 2010 Anand Chokkavelu |
5 Defense and Capital Goods Stocks Near 52-Week Lows Trolling the bottom for upside potential.  |
The Motley Fool December 31, 2010 Alyce Lomax |
Sin Stocks Revisited Investors would do well to track the changing face of social responsibility.  |
The Motley Fool December 31, 2010 Rick Aristotle Munarriz |
7 Reasons to Worry About Next Year Watch your step on the way down next year. Despite the buoyant optimism, there are still plenty of companies projected to post lower earnings in 2011 than they did in 2010.  |
The Motley Fool December 31, 2010 Brian Orelli |
CEL-SCI Investors Cheer a Bit Too Loudly Finally, a phase 3 trial for cancer therapy Multikine.  |
The Motley Fool December 31, 2010 Anders Bylund |
Here's That Dreaded Reverse Split! Evergreen Solar goes through with a much-derided plan to appease the Nasdaq overlords. Will it really matter in the end?  |
| <Older 46291-46300 Newer> Return to current articles. |